Abstract:Apoptosis is involved in the pathology of a variety of diseases. The measurement of apoptosis will help us to evaluate the onset of disease and the effect of therapeutic interventions. In addition, the increased demand for understanding the early stages of apoptosis is pushing the envelope for solutions in early instance real-time monitoring of death kinetics. Here we present a novel electrochemiluminescent cytosensing strategy to quantitate apoptotic cell numbers, screen some anticancer drugs, and evaluate their effects on hepatocarcinoma cell line (HepG2) cells by utilizing the human antiphosphatidyl serine antibody (APSA) conjugated Ru(bpy)(3)(2+)-encapsulated silica nanoparticle (APSA-SiO2@Ru) as the detection probe. HepG2 cells were easily immobilized on the arginine-glycine-aspartic acid-serine (RGDS)-multiwalled carbon nanotubes (RGDS-MWCNTs) nanocomposite by the specific combination of RGD domains with integrin receptors on the cell surface. Then APSA-SiO2@Ru was introduced to the surface of apoptosis cells through the specific interaction between APSA and phosphatidylserine (PS) that distributed on the outer membrane of apoptotic cells. On the basis of the signal amplification of the APSA-SiO2@Ru nanoprobe, the cytosensor could respond as low as 800 cells mL(-1), showing very high sensitivity. In addition, the dynamic alterations of surface PS expression on HepG2 cells in response to drugs and the cell heterogeneity were also demonstrated. The strategy presented a promising platform for highly sensitive cytosensing and convenient screening of some clinically available anticancer drugs.

Activatable Selenium-Containing Fluorescent Apoptotic Agent for Biosensing and Tracing Cancer Cell Apoptosis

Real-time Monitoring of Cell Apoptosis and Drug Screening Using Fluorescent Light-Up Probe with Aggregation-Induced Emission Characteristics.

Smart Plasmonic Nanozyme Enhances Combined Chemo-photothermal Cancer Therapy and Reveals Tryptophan Metabolic Apoptotic Pathway

Mitochondria-Targeted Two-Photon Fluorescent Photosensitizers for Cancer Cell Apoptosis via Spatial Selectability.

Evaluating Visually A New Apoptosis-Induced Reagent By A Ratiometric Two-Photon Fluorescent Ph Probe

Signal amplification cytosensor for evaluation of drug-induced cancer cell apoptosis.

Dual-Modal Apoptosis Assay Enabling Dynamic Visualization of ATP and Reactive Oxygen Species in Living Cells

Targetable Mesoporous Silica Nanoprobes for Mapping the Subcellular Distribution of H2Se in Cancer Cells

Real-Time in Situ Sequential Fluorescence Activation Imaging of Cyt C and Caspase-9 with a Gold-Selenium-Bonded Nanoprobe.

Design of "smart" Probes for Optical Imaging of Apoptosis

Aggregation-induced Emission Near-Infrared Photosensitizer with Time-Responsive Dual-Organelles Targeting for Accelerating Cancer Cells Apoptosis and Metastasis Inhibition

Structure-inherent Near-Infrared Fluorescent Probe Mediates Apoptosis Imaging and Targeted Drug Delivery in Vivo

Selenomethionine-Conjugated Extracellular Vesicles for ROS-Mediated Cell Apoptosis

Tracking Cell Apoptosis Based on Mitochondria and Cell Membrane Imaging

Synthesis of Selenazolopyridine Derivatives with Capability to Induce Apoptosis in Human Breast Carcinoma MCF-7 Cells Through Scavenge of Intracellular ROS.

The Signal Transduction In Ros-Mediated Apoptosis Induced By Selenium Compounds

A Flim Photosensitizer: Targeting “affinal” Suborganelles to Accelerate Cancer Cell Oxidative Stress and Apoptosis

Light‐Up Probe for Targeted and Activatable Photodynamic Therapy with Real‐Time In Situ Reporting of Sensitizer Activation and Therapeutic Responses

Aptamer Conjugate-Based Ratiometric Fluorescent Probe for Precise Imaging of Therapy-Induced Cancer Senescence.

Fluorescence Activation Imaging Of Cytochrome C Released From Mitochondria Using Aptameric Nanosensor

Novel Polarity Fluorescent Probe for Dual-Color Visualization of Lysosomes and Plasma Membrane During Apoptosis.